Back to All Studies

The drug pimobendan is used in cats and dogs to treat congestive heart failure caused by various types of heart disease. While it is relatively easy to give dogs the treatment orally, the large tablets can be difficult for cat owners to administer, which results in missed doses and suboptimal disease control. Researchers will investigate delivering a transdermal gel formulation of pimobendan to healthy cats. They will then compare whether transdermal and oral delivery methods are equally effective in delivering therapeutic levels of pimobendan. Use of a transdermal gel formulation for cats with heart failure would give those that are intolerant of pills the best chance for survival and optimal quality of life.

Study ID
D15FE-802
Study Status
Complete
Start Date
10/01/2014
Grant amount awarded
$8,352
Grant recipient
North Carolina State University
Study country
United States
Investigator
Sandra P. Tou, DVM
Study category
Cardiovascular